SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-004557
Filing Date
2017-01-27
Accepted
2017-01-27 16:26:15
Documents
10
Effectiveness Date
2017-01-27

Document Format Files

Seq Description Document Type Size
1 S-8 a17-3113_1s8.htm S-8 155434
2 EX-5.1 a17-3113_1ex5d1.htm EX-5.1 10367
3 EX-10.1 a17-3113_1ex10d1.htm EX-10.1 215793
4 EX-10.2 a17-3113_1ex10d2.htm EX-10.2 212839
5 EX-10.3 a17-3113_1ex10d3.htm EX-10.3 21364
6 EX-10.4 a17-3113_1ex10d4.htm EX-10.4 193979
7 EX-10.5 a17-3113_1ex10d5.htm EX-10.5 6594
8 EX-23.1 a17-3113_1ex23d1.htm EX-23.1 4401
9 EX-23.3 a17-3113_1ex23d3.htm EX-23.3 4863
10 GRAPHIC g31131kti001.jpg GRAPHIC 3715
  Complete submission text file 0001104659-17-004557.txt   832000
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-215787 | Film No.: 17554101
SIC: 2834 Pharmaceutical Preparations